注册/登陆 | 帮助 登陆后,你将获得更多的服务和功能...
资源简介

Effective Gene-Viral Therapy for Telomerase-Positive Cancers by SelectiveReplicative-Competent Adenovirus Combining with Endostatin Gene

PDF文档 PDF文档 494KB | 浏览次数:1383
ABSTRACT Gene-viral therapy, which uses replication-selective transgene-expressing viruses to manage tumors, can exploit the virtues of gene therapy and virotherapy and overcome the limitations of conventional gene therapy. Using a human telomerase reverse transcriptase-targeted replicative adenovirus as an antiangiogenic gene transfer vector to target new angiogenesis and making use of its unrestrained proliferation are completely new concepts in tumor management. CNHK300-mE is a selective replication transgene-expressing adenovirus constructed to carry mouse endostatin gene therapeutically. Infection with CNHK300-mE was associated with selective replication of the adenovirus and production of mouse endostatin in telomerase-positive cancer cells. Endostatin secreted from a human gastric cell line, SGC-7901, infected with CNHK300-mE was significantly higher than that infected with nonreplicative adenovirus Ad-mE in vitro (800  94.7 ng/ml versus 132.9  9.9 ng/ml) and in vivo (610  42 ng/ml versus 126  13 ng/ml). Embryonic chorioallantoic membrane assay showed that the mouse endostatin secreted by CNHK300-mE inhibited angiogenesis efficiently and also induced distortion of pre-existing vasculature. CNHK300-mE exhibited a superior suppression of xenografts in nude mice compared with CNHK300 and AdmE. In summary, we provided a more efficient gene-viral therapy strategy by combining oncolysis with antiangiogenesis.
添加到收藏(请先登陆)


请给资源评分:
共评分6次


注意:如果不能正常下载,请使用flashget等下载软件。
如果无法正常浏览文件,可能是因为需要解压缩,请下载RAR解压缩软件

声明:任何单位或个人认为通过本网站的内容可能涉嫌侵犯其合法权益,应该及时向我们的网站书面反馈,并提供身份证明、权属证明及详细侵权情况证明,在收到上述法律文件后,我们将会尽快移除被控侵权内容。本资料仅供浏览,不允许保存及传播!

资源详细信息: 上传用户:gene 加为好友(请先登陆)
文件类型:文章 - PDF文档 PDF文档
文件大小:494KB
资源来源:转载 - CANCER RESEARCH 64, August 1, 2004
上传时间:2007-01-04 16:32:26
资源标签:基因治疗
所属频道:基因治疗
摘要浏览:1383次